|
|
Volumn 342, Issue 15, 2000, Pages 1120-1122
|
|
Underlying causes and survival in patients with heart failure
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOXORUBICIN;
AMYLOIDOSIS;
CARDIOMYOPATHY;
CARDIOVASCULAR DISEASE;
DRUG INDUCED DISEASE;
EDITORIAL;
HEART FAILURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IDIOPATHIC DISEASE;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROGNOSIS;
SARCOIDOSIS;
SURVIVAL RATE;
CARDIOMYOPATHIES;
HEART FAILURE, CONGESTIVE;
HUMANS;
MYOCARDIAL ISCHEMIA;
PROGNOSIS;
SURVIVAL ANALYSIS;
|
|
EID: 0034643398
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200004133421509 Document Type: Editorial |
|
Times cited : (20)
|
|
References (16)
|
